12 results
8-K
EX-99.3
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
products in Wound & Surgical Innovate & Diversify Build leadership position Product Portfolio to Consider additional inorganic additions in Wound & Surgical
8-K
EX-99.2
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
31, 2024 for a 5 reconciliation to the nearest GAAP measure.
Evolving Our Strategic Priorities from 2023 to 2024 2023 2024 Innovate & diversify
8-K
EX-99.1
MDXG
Mimedx Group Inc
28 Dec 23
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock
4:30pm
and innovate. We are eternally grateful to these two exceptional partners and for the support they have provided MIMEDX.”
Martin P. Sutter, co
8-K
EX-99.1
e5y6wtjni5zdm or2
30 Nov 22
Regulation FD Disclosure
7:00am
8-K
EX-99.1
h4o2am
17 Nov 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
tdgkpeefpx8 5ghang
30 Jun 22
Regulation FD Disclosure
4:38pm
DEFA14A
fth4gl7z3v jnb
18 May 22
Additional proxy soliciting materials
4:26pm
8-K
EX-99.1
5bi kqp7elm
3 May 22
MIMEDX Announces First Quarter 2022 Operating and Financial Results
4:37pm
8-K
EX-99.2
tx0xwkj0 nom7
30 Oct 20
MiMedx Announces Relisting on Nasdaq
5:28pm
8-K
EX-99.2
qxsutm09o qmptu4mhx
21 Sep 20
Regulation FD Disclosure
6:15am
- Prev
- 1
- Next